Mouse UL16 binding protein-like transcript 1 (Mult1) is highly expressed in breast cancer cells carrying p53, which can bind to NK group 2 member D receptors (NKG2DRs) on NK cells, leading to NK activation and increased IFN-γ production, thus enabling the immune-eradication of cancer cells [164]. Here, TP53 is linked to breast cancer.